Reference number : 236-2014-2015-Q1-00207, amendment number : , agreement type : G, recipient legal name : IWASHKIW, Jeremy A, recipient country : US, recipient province : nan, recipient city : Boston, recipient postal code : nan, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 150000.0, agreement start date : 2014-08-01, agreement end date : 2017-07-31, description english : Application of Protein Capsular Matrix Vaccine Technology to the Development of a Novel Form of Killed Whole Cell Vaccines, description french : Application of Protein Capsular Matrix Vaccine Technology to the Development of a Novel Form of Killed Whole Cell Vaccines, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2014-15 to 2017-18)

Start date may be subject to change.  Funding for awards must commence within 12 months of the date of offer., additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2014-15 à 2017-18)

La date de début peut être sujet au changement.  Le financement des bourses doit commencer dans les 12 mois suivant la date à laquelle elles ont été offertes., owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada